High Lipoprotein(a) and Valvular and Cardiovascular Events in Patients With Aortic Stenosis
Arnaud S. Girard, Neil Craig, Peter E. Thomas, Marie-Ange Fleury, Børge G. Nordestgaard, Marie-Annick Clavel, Philippe Pibarot, Marc R. Dweck, Pia R. Kamstrup, Benoit J. Arsenault · 2026
Read High Lipoprotein(a) and Valvular and Cardiovascular Events in Patients With Aortic Stenosis by Arnaud S. Girard, Neil Craig, Peter E. Thomas, Marie-Ange Fleury, Børge G. Nordestgaard, Marie-Annick Clavel, Philippe Pibarot, Marc R. Dweck, Pia R. Kamstrup, Benoit J. Arsenault (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13543901.txt.
Description
Arnaud S Girard and co-authors ask in 2026 if a blood fat called lipoprotein(a) raises risk in people with a narrowed aortic valve. The condition, the most common valve disease in Western countries, stiffens the valve with calcium over time. The fat particle is set largely by genes and is known to harm arteries.
In patients with this valve disease, those with high levels of the fat had more valve and heart events than those with low levels. The link held as its own signal, not just a shadow of other risks. Testing for it may help doctors judge which patients need closer watch.
Catalog record
| CREATOR | Arnaud S. Girard, Neil Craig, Peter E. Thomas, Marie-Ange Fleury, Børge G. Nordestgaard, Marie-Annick Clavel, Philippe Pibarot, Marc R. Dweck, Pia R. Kamstrup, Benoit J. Arsenault |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 11 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |